Healthcare provider profile · identity verified

Stephanie Rutterbush, MD

Family Practice · LEWISTON, MI · NPI 1649652298

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	591	191
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	415	79
Lisinopril	Lisinopril	414	123
Omeprazole	Omeprazole	395	128
Levothyroxine Sodium	Levothyroxine Sodium	369	101
Amlodipine Besylate	Amlodipine Besylate	363	115
Rosuvastatin Calcium	Rosuvastatin Calcium	344	112
Losartan Potassium	Losartan Potassium	303	94
Gabapentin	Gabapentin	236	65
Metoprolol Succinate	Metoprolol Succinate	224	72
Metformin Hcl	Metformin Hcl	223	69
Hydrochlorothiazide	Hydrochlorothiazide	217	73
Simvastatin	Simvastatin	183	57
Furosemide	Furosemide	181	61
Tamsulosin Hcl	Tamsulosin Hcl	150	50
Pantoprazole Sodium	Pantoprazole Sodium	146	41
Metoprolol Tartrate	Metoprolol Tartrate	139	49
Prednisone	Prednisone	139	90
Albuterol Sulfate Hfa	Albuterol Sulfate	138	63
Ezetimibe	Ezetimibe	135	44
Potassium Chloride	Potassium Chloride	132	38
Fluticasone Propionate	Fluticasone Propionate	128	68
Eliquis	Apixaban	122	30
Jardiance	Empagliflozin	115	36
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	114	32
Sertraline Hcl	Sertraline Hcl	109	32
Pravastatin Sodium	Pravastatin Sodium	107	32
Mounjaro	Tirzepatide	105	21
Meloxicam	Meloxicam	104	39
Famotidine	Famotidine	100	37
Tramadol Hcl	Tramadol Hcl	97	27
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	95	17
Allopurinol	Allopurinol	94	27
Metformin Hcl Er	Metformin Hcl	92	29
Trazodone Hcl	Trazodone Hcl	90	33
Duloxetine Hcl	Duloxetine Hcl	85	21
Alprazolam	Alprazolam	84	27
Montelukast Sodium	Montelukast Sodium	80	27
Trulicity	Dulaglutide	77	23
Celecoxib	Celecoxib	76	30
Escitalopram Oxalate	Escitalopram Oxalate	75	27
Glimepiride	Glimepiride	73	21
Warfarin Sodium	Warfarin Sodium	72	19
Spironolactone	Spironolactone	71	21
Bupropion Xl	Bupropion Hcl	70	25
Pregabalin	Pregabalin	70	17
Carvedilol	Carvedilol	68	24
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	65	34
Venlafaxine Hcl Er	Venlafaxine Hcl	65	17
Ventolin Hfa	Albuterol Sulfate	63	26
Clopidogrel	Clopidogrel Bisulfate	60	19
Buspirone Hcl	Buspirone Hcl	59	18
Amitriptyline Hcl	Amitriptyline Hcl	56	18
Glipizide Er	Glipizide	56	19
Januvia	Sitagliptin Phosphate	56	17
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	55	21
Ibuprofen	Ibuprofen	54	27
Oxycodone Hcl	Oxycodone Hcl	54	13
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	54	19
Diazepam	Diazepam	53	17
Mirtazapine	Mirtazapine	53	20
Oxybutynin Chloride Er	Oxybutynin Chloride	51	14
Alendronate Sodium	Alendronate Sodium	49	20
Zolpidem Tartrate	Zolpidem Tartrate	48	11
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	47	13
Ozempic	Semaglutide	46	14
Fluoxetine Hcl	Fluoxetine Hcl	45	12
Xarelto	Rivaroxaban	45	14
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	44	14
Meclizine Hcl	Meclizine Hcl	44	23
Atenolol	Atenolol	42	12
Ondansetron Odt	Ondansetron	41	13
Enalapril Maleate	Enalapril Maleate	40	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	39	33
Doxycycline Hyclate	Doxycycline Hyclate	38	31
Nystatin	Nystatin	38	21
Acetaminophen-Codeine	Acetaminophen With Codeine	37	suppressed
Ropinirole Hcl	Ropinirole Hcl	37	11
Tolterodine Tartrate Er	Tolterodine Tartrate	36	11
Pioglitazone Hcl	Pioglitazone Hcl	35	11
Topiramate	Topiramate	35	14
Fentanyl	Fentanyl	34	suppressed
Fenofibrate	Fenofibrate	33	11
Fluconazole	Fluconazole	33	23
Triamcinolone Acetonide	Triamcinolone Acetonide	32	19
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	31	15
Synthroid	Levothyroxine Sodium	30	suppressed
Finasteride	Finasteride	29	11
Methocarbamol	Methocarbamol	29	13
Fenofibrate	Fenofibrate Nanocrystallized	28	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	28	11
Chlorthalidone	Chlorthalidone	27	suppressed
Estradiol	Estradiol	27	12
Citalopram Hbr	Citalopram Hydrobromide	26	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	26	suppressed
Lorazepam	Lorazepam	26	suppressed
Paroxetine Hcl	Paroxetine Hcl	26	11
Azithromycin	Azithromycin	25	22
Clonazepam	Clonazepam	25	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	25	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	24	11
Mupirocin	Mupirocin	24	22
Quetiapine Fumarate	Quetiapine Fumarate	24	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	24	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	23	14
Sumatriptan Succinate	Sumatriptan Succinate	23	suppressed
Amoxicillin	Amoxicillin	22	12
Primidone	Primidone	21	suppressed
Cephalexin	Cephalexin	20	16
Gemfibrozil	Gemfibrozil	20	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	20	suppressed
Spiriva Handihaler	Tiotropium Bromide	20	suppressed
Humalog Kwikpen U-100	Insulin Lispro	19	suppressed
Ipratropium Bromide	Ipratropium Bromide	19	11
Diltiazem 24hr Er (La)	Diltiazem Hcl	18	suppressed
Donepezil Hcl	Donepezil Hcl	18	suppressed
Doxepin Hcl	Doxepin Hcl	18	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	18	suppressed
Farxiga	Dapagliflozin Propanediol	18	suppressed
Memantine Hcl	Memantine Hcl	18	suppressed
Nifedipine Er	Nifedipine	18	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	18	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	17	15
Clonidine Hcl	Clonidine Hcl	17	suppressed
Ketoconazole	Ketoconazole	17	11
Methotrexate	Methotrexate Sodium	17	suppressed
Naproxen	Naproxen	17	suppressed
Solifenacin Succinate	Solifenacin Succinate	17	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	16	15
Breo Ellipta	Fluticasone/Vilanterol	16	suppressed
Armour Thyroid	Thyroid,pork	15	suppressed
Hydrocortisone	Hydrocortisone	15	suppressed
Lamotrigine	Lamotrigine	15	suppressed
Loperamide	Loperamide Hcl	15	suppressed
Sucralfate	Sucralfate	15	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	15	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	15	suppressed
Baclofen	Baclofen	14	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	14	suppressed
Bumetanide	Bumetanide	14	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	14	suppressed
Fenofibrate	Fenofibrate,micronized	14	suppressed
Linzess	Linaclotide	14	suppressed
Lovastatin	Lovastatin	14	suppressed
Novolog Flexpen	Insulin Aspart	14	suppressed
Propranolol Hcl Er	Propranolol Hcl	14	suppressed
Verapamil Er	Verapamil Hcl	14	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	13	suppressed
Ibandronate Sodium	Ibandronate Sodium	13	suppressed
Nyamyc	Nystatin	13	suppressed
Propranolol Hcl	Propranolol Hcl	13	suppressed
Azelastine Hcl	Azelastine Hcl	12	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	12	suppressed
Hydralazine Hcl	Hydralazine Hcl	12	suppressed
Irbesartan	Irbesartan	12	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	12	suppressed
Metronidazole	Metronidazole	12	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	suppressed
Terbinafine Hcl	Terbinafine Hcl	12	suppressed
Tresiba Flextouch U-200	Insulin Degludec	12	suppressed
Valacyclovir	Valacyclovir Hcl	12	suppressed
Benazepril Hcl	Benazepril Hcl	11	suppressed
Incruse Ellipta	Umeclidinium Bromide	11	suppressed
Lansoprazole	Lansoprazole	11	suppressed
Morphine Sulfate	Morphine Sulfate	11	suppressed
Morphine Sulfate Er	Morphine Sulfate	11	suppressed
Myrbetriq	Mirabegron	11	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	11	11
Nystop	Nystatin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error